FibroGen, Inc. (FGEN)
NASDAQ: FGEN · Real-Time Price · USD
8.42
+0.17 (2.06%)
At close: Dec 5, 2025, 4:00 PM EST
8.58
+0.16 (1.90%)
After-hours: Dec 5, 2025, 6:54 PM EST
FibroGen Market Cap
FibroGen has a market cap or net worth of $34.06 million as of December 5, 2025. Its market cap has increased by 0.18% in one year.
Market Cap
34.06M
Enterprise Value
-64.44M
1-Year Change
0.18%
Ranking
Category
Stock Price
$8.42
Market Cap Chart
Since November 14, 2014, FibroGen's market cap has decreased from $1.22B to $34.06M, a decrease of -97.22%. That is a compound annual growth rate of -27.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 33.40M | -37.45% |
| Dec 31, 2024 | 53.40M | -38.76% |
| Dec 29, 2023 | 87.20M | -94.21% |
| Dec 30, 2022 | 1.51B | 15.15% |
| Dec 31, 2021 | 1.31B | -61.28% |
| Dec 31, 2020 | 3.38B | -9.80% |
| Dec 31, 2019 | 3.74B | -4.85% |
| Dec 31, 2018 | 3.93B | 1.17% |
| Dec 29, 2017 | 3.89B | 187.60% |
| Dec 30, 2016 | 1.35B | -27.68% |
| Dec 31, 2015 | 1.87B | 22.78% |
| Dec 31, 2014 | 1.52B | 24.27% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |